Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Zhu, Dalong, Li, Xiaoying, Ma, Jianhua, Zeng, Jiao'e, Gan, Shenglian, Dong, Xiaolin, Yang, Jing, Lin, Xiaohong, Cai, Hanqing, Song, Weihong, Li, Xuefeng, Zhang, Keqin, Zhang, Qiu, Lu, Yibing, Bu, Ruifang, Shao, Huige, Wang, Guixia, Yuan, Guoyue, Ran, Xingwu, Liao, Lin, Zhao, Wenjuan, Li, Ping, Sun, Li, Shi, Lixin, Jiang, Zhaoshun, Xue, Yaoming, Jiang, Hongwei, Li, Quanmin, Li, Zongbao, Fu, Maoxiong, Liang, Zerong, Guo, Lian, Liu, Ming, Xu, Chun, Li, Wenhui, Yu, Xuefeng, Qin, Guijun, Yang, Zhou, Su, Benli, Zeng, Longyi, Geng, Houfa, Shi, Yongquan, Zhao, Yu, Zhang, Yi, Yang, Wenying, Chen, Li
Published in Nature medicine (01.05.2022)
Published in Nature medicine (01.05.2022)
Get full text
Journal Article
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Yang, Wenying, Zhu, Dalong, Gan, Shenglian, Dong, Xiaolin, Su, Junping, Li, Wenhui, Jiang, Hongwei, Zhao, Wenjuan, Yao, Minxiu, Song, Weihong, Lu, Yibing, Zhang, Xiuzhen, Li, Huifang, Wang, Guixia, Qiu, Wei, Yuan, Guoyue, Ma, Jianhua, Li, Wei, Li, Ziling, Wang, Xiaoyue, Zeng, Jiao'e, Yang, Zhou, Liu, Jingdong, Liang, Yongqian, Lu, Song, Zhang, Huili, Liu, Hui, Liu, Ping, Fan, Kuanlu, Jiang, Xiaozhen, Li, Yufeng, Su, Qing, Ning, Tao, Tan, Huiwen, An, Zhenmei, Jiang, Zhaoshun, Liu, Lijun, Zhou, Zunhai, Zhang, Qiu, Li, Xuefeng, Shan, Zhongyan, Xue, Yaoming, Mao, Hong, Shi, Lixin, Ye, Shandong, Zhang, Xiaomei, Sun, Jiao, Li, Ping, Yang, Tao, Li, Feng, Lin, Jingna, Zhang, Zhinong, Zhao, Ying, Li, Ruonan, Guo, Xiaohui, Yao, Qi, Lu, Weiping, Qu, Shen, Li, Hongmei, Tan, Liling, Wang, Wenbo, Yao, Yongli, Chen, Daoxiong, Li, Yulan, Gao, Jialin, Hu, Wen, Fei, Xiaoqiang, Wu, Tianfeng, Dong, Song, Jin, Wenlong, Li, Chenzhong, Zhao, Dong, Feng, Bo, Zhao, Yu, Zhang, Yi, Li, Xiaoying, Chen, Li
Published in Nature medicine (01.05.2022)
Published in Nature medicine (01.05.2022)
Get full text
Journal Article
Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
Ji, Linong, Ma, Jianhua, Lu, Weiping, Liu, Jingdong, Zeng, Jiao’e, Yang, Jialin, Li, Wei, Zhang, Xiuzhen, Xiao, Xinhua, Takayanagi, Gen, Wang, Yi
Published in Journal of diabetes investigation (01.04.2021)
Published in Journal of diabetes investigation (01.04.2021)
Get full text
Journal Article
Inside Front Cover
Zeng, Jiao'e, Gan, Shenglian, Mi, Nianrong, Liu, Yunfeng, Su, Xiaofei, Zhang, Wenli, Zhang, Juan, Yu, Fang, Dong, Xiaolin, Han, Minmin, Luo, Jianfeng, Zhang, Yi, Chen, Li, Ma, Jianhua
Published in Diabetes, obesity & metabolism (01.10.2023)
Published in Diabetes, obesity & metabolism (01.10.2023)
Get full text
Journal Article
Diabetes remission in drug‐naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study
Zeng, Jiao'e, Gan, Shenglian, Mi, Nianrong, Liu, Yunfeng, Su, Xiaofei, Zhang, Wenli, Zhang, Juan, Yu, Fang, Dong, Xiaolin, Han, Minmin, Luo, Jianfeng, Zhang, Yi, Chen, Li, Ma, Jianhua
Published in Diabetes, obesity & metabolism (01.10.2023)
Published in Diabetes, obesity & metabolism (01.10.2023)
Get full text
Journal Article
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
Zhu, Dalong, Gan, Shenglian, Liu, Yu, Ma, Jianhua, Dong, Xiaolin, Song, Weihong, Zeng, Jiao'e, Wang, Guixia, Zhao, Wenjuan, Zhang, Qiu, Li, Yukun, Fang, Hui, Lv, Xiaofeng, Shi, Yongquan, Tian, Haoming, Ji, Linong, Gao, Xin, Zhang, Lihui, Bao, Yuqian, Lei, Minxiang, Li, Ling, Zeng, Longyi, Li, Xiaoying, Hou, Xinghua, Zhao, Yu, Hu, Tianxin, Ge, Xiaoyun, Zhao, Guiyu, Li, Yongguo, Zhang, Yi, Chen, Li
Published in The lancet. Diabetes & endocrinology (01.08.2018)
Published in The lancet. Diabetes & endocrinology (01.08.2018)
Get full text
Journal Article
115-LB: Dorzagliatin Showed Sustained Remission in an Observational Study after Discontinuation of Treatment in T2D Patients Who Achieved Good Glycemic Control with Dorzagliatin Monotherapy
ZENG, JIAOE, GAN, SHENGLIAN, DONG, XIAOLIN, LIU, YUNFENG, SU, XIAOFEI, LUO, JIANFENG, MA, JIANHUA
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment‐naïve Chinese patients: Analysis of results from the CONSENT trial
Ji, Linong, Liu, Jing, Yang, Jing, Li, Yufeng, Liang, Li, Zhu, Dalong, Li, Quanmin, Ma, Tianrong, Xu, Haiyan, Yang, Yanlan, Zeng, Jiaoe, Feng, Bo, Qu, Shen, Li, Yiming, Ma, Lizhen, Lin, Shanshan, Wang, Jianping, Li, Wei, Song, Weihong, Li, Xiaoxing, Luo, Yong, Xi, Shugang, Lin, Mei, Liu, Yu, Liang, Zerong
Published in Diabetes, obesity & metabolism (01.04.2018)
Published in Diabetes, obesity & metabolism (01.04.2018)
Get full text
Journal Article
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin
Chen, Xi, Xu, Yongping, Zhang, Jianhua, Shao, Shiyin, Duan, Yanran, Liu, Peiwen, Shen, Liya, Zhang, Jing, Zeng, Jiaoe, Lin, Mei, Zhao, Shi, Ma, Jianhua, Zhao, Tao, Hu, Juping, Liao, Yong, Chen, Xiaowen, Hu, Shufang, Xue, Yaoming, Zeng, Zhaoyang, He, Wentao, Liu, Zhelong, Li, Wenjun, Liu, Liegang, Yin, Ping, Yu, Xuefeng
Published in Endocrine practice (01.08.2021)
Published in Endocrine practice (01.08.2021)
Get more information
Journal Article
Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double‐blind placebo‐controlled Phase 3 study in mainland China, Taiwan, and Hong Kong
Pan, Changyu, Han, Ping, Ji, Qiuhe, Li, Chengjiang, Lu, Juming, Yang, Jinkui, Li, Wenhui, Zeng, Jiaoe, Hsieh, An‐Tsz, Chan, Juliana
Published in Journal of diabetes (01.04.2017)
Published in Journal of diabetes (01.04.2017)
Get full text
Journal Article
Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double‐blind placebo‐controlled Phase 3 study in mainland China, Taiwan, and Hong Kong: 阿格列汀治疗2型糖尿病患者的疗效和安全性:在中国大陆,台湾,香港进行的一项多中心随机双盲安慰剂对照的3期研究
Pan, Changyu, Han, Ping, Ji, Qiuhe, Li, Chengjiang, Lu, Juming, Yang, Jinkui, Li, Wenhui, Zeng, Jiaoe, Hsieh, An‐Tsz, Chan, Juliana
Published in Journal of diabetes (01.04.2017)
Published in Journal of diabetes (01.04.2017)
Get full text
Journal Article